10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001144204-19-038191`
Period End Date	20190630
Filing Date	20190807
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	enzn-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 46 Cash Flow Statement 21 Stockholders Equity 19

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$3.37M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$7.00M	USD	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$7.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$96.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$70.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.43M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$15.51M	USD	Point-in-time
Total assets	`Assets`	$12.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$439.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$348.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$78.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$107.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$455.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$517.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at June 30, 2019 and December 31, 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at June 30, 2019 and December 31, 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$81.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.49M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$12.40M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.51M	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Royalties, net	`RoyaltyRevenueAndMilestones`	$156.00K	USD	2 Qtrs
Royalties, net	`RoyaltyRevenueAndMilestones`	$61.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$207.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$76.00K	USD	2 Qtrs
Total revenues	`Revenues`	$76.00K	USD	2 Qtrs
Total revenues	`Revenues`	$207.00K	USD	1 Quarter
Total revenues	`Revenues`	$61.00K	USD	1 Quarter
Total revenues	`Revenues`	$156.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$588.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$267.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$228.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$546.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$267.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$228.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$546.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$588.00K	USD	2 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-21.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-390.00K	USD	2 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-512.00K	USD	2 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-206.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-206.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-307.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-392.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-513.00K	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	2 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	2 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	2 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	2 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter

Cash Flow Statement 21 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-513.00K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-392.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$88.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-480.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-512.00K	USD	2 Qtrs
Common stock dividends	`PaymentsOfDividendsCommonStock`	$2.65M	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	$2.65M	USD	2 Qtrs
Common stock dividends	`PaymentsOfDividendsCommonStock`	-	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-512.00K	USD	2 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.13M	USD	2 Qtrs
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.97M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.97M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37M	USD	Point-in-time

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.84M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-206.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-307.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-392.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-513.00K	USD	2 Qtrs
Common stock dividend	`DividendsCommonStockStock`	$2.65M	USD	1 Quarter
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.84M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.